Company intelligence / Profile preview

Blue Thorn

Las Vegas, Nevada, United States

Ownership: Private
Development stage: Other

Overview

Blue Thorn is a U.S. healthcare consulting company founded by physician executive Terry McInnis. The firm appears to focus on health policy, value-based care, delivery-system transformation, medication management, and strategic advisory work for providers, health plans, pharmaceutical manufacturers, government stakeholders, and advocacy organizations. Publicly available descriptions emphasize consulting engagements rather than development of proprietary therapeutics, clinical-stage assets, or a drug pipeline. Based on the available evidence, Blue Thorn is healthcare-related but is not a biotech or pharmaceutical drug developer.

Industry: Consulting

Partnerships

Health2 Resources

Beyond the preview

Go deeper on Blue Thorn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blue Thorn.

Explore the full profile